The recent elections showcased the intricate relationship between medicine and politics, highlighting how healthcare professionals are seeking to make their mark in legislative bodies. With all 435 House of Representatives seats up for grabs, the election was not merely a battleground for incumbent politicians, but also for a diverse array of healthcare-affiliated candidates. As the
Health
In recent years, the conversation surrounding transparency in scientific publishing has gained momentum, with an essential element being the disclosure of conflicts of interest (COI). Conflict of interest statements serve to acknowledge any potential biases that could affect research outcomes, fostering accountability among authors and journals. Despite the recognized need for transparency, a study indicates
The recent approval of minocycline hydrochloride extended-release capsules, branded as Emrosi, marks a significant advancement in the treatment of papulopustular rosacea in adults. Announced by Journey Medical, this FDA approval comes after thorough evaluations stemming from extensive phase III clinical trials, specifically MVOR-1 and MVOR-2, that included a sample size of 653 participants. This new
Schizophrenia, a severe mental health condition, has profound effects on individuals’ quality of life and overall longevity. Recent longitudinal studies shed light on the consequences of relapse for patients deemed stable on antipsychotic medications. Research by Dr. Christoph Correll at the Zucker School of Medicine emphasized that even one relapse can significantly elevate all-cause mortality
The prevalence of major depressive disorder (MDD) coupled with insomnia represents a significant challenge in psychiatric care. Traditional antidepressants often fall short in addressing the intricacies of both conditions adequately. Recent phase III clinical trials investigating the drug seltorexant, a selective orexin-2 receptor antagonist, have illuminated its potential to improve symptoms associated with MDD and
In a striking deviation from traditional public health protocols, the Southwest District Health department of Idaho has ceased providing COVID-19 vaccinations to its residents in six counties. This decision, reached by a narrow 4-3 vote by the department’s board, is unprecedented—marking the district as the first in the United States to limit access to COVID-19
Obstructive sleep apnea (OSA) is a prevalent condition among children that can lead to significant health issues if left untreated. New research has illuminated a potential link between vitamin D deficiency and the severity of OSA in pediatric patients. This association raises important questions about screening and treatment approaches that could mitigate the impacts of
In recent years, public health has faced a plethora of challenges, significantly altering the landscape of global healthcare policy. A report from the World Health Organization (WHO) indicates that tuberculosis (TB) has surged ahead of COVID-19 as the foremost infectious disease killer worldwide. With an alarming statistic of 8 million new infections and around 1.25
The recent allegations surrounding organ donation practices have sent shockwaves through the medical community and the wider public, particularly following an incident in Kentucky involving a man who was mistakenly declared dead yet was later found to be alive. This event has ignited a wave of concern over the reliability and ethics of the organ
Recent developments in the treatment of heart failure have stirred a renewed interest in the potential of targeted pharmacological strategies. One such agent, finerenone (Kerendia), has been subjected to significant scrutiny in clinical trials, particularly regarding its renal benefits for patients with heart failure and either mildly reduced or preserved ejection fraction. Findings from the